|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
108,674,000 |
Market
Cap: |
57.47(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2298 - $2.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 707 |
Guru Rank Value : 1.9 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
816,825 |
816,825 |
Total Buy Value |
$0 |
$0 |
$194,885 |
$194,885 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
4 |
4 |
Total Shares Sold |
211,204 |
267,396 |
419,842 |
591,605 |
Total Sell Value |
$130,313 |
$170,773 |
$340,560 |
$980,941 |
Total People Sold |
5 |
5 |
6 |
9 |
Total Sell Transactions |
5 |
10 |
23 |
41 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Newell Joe |
Chief Tech. Operations Officer |
|
2019-02-01 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
33,358 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2019-01-24 |
4 |
AS |
$34.98 |
$136,783 |
I/I |
(3,900) |
296,452 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2019-01-23 |
4 |
AS |
$34.84 |
$136,650 |
I/I |
(3,900) |
300,352 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2019-01-10 |
4 |
AS |
$33.93 |
$133,581 |
I/I |
(3,900) |
4,078 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2019-01-09 |
4 |
AS |
$34.51 |
$135,889 |
I/I |
(3,900) |
7,978 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2019-01-02 |
4 |
AS |
$35.00 |
$52,500 |
D/D |
(1,500) |
31,858 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2019-01-02 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
33,358 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-12-28 |
4 |
AS |
$34.60 |
$135,340 |
I/I |
(3,900) |
11,878 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-12-27 |
4 |
AS |
$32.82 |
$128,893 |
I/I |
(3,900) |
15,778 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-12-13 |
4 |
AS |
$42.75 |
$166,725 |
I/I |
(3,900) |
19,678 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-12-12 |
4 |
AS |
$42.56 |
$165,984 |
I/I |
(3,900) |
23,578 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2018-12-03 |
4 |
AS |
$40.61 |
$61,704 |
D/D |
(1,500) |
31,858 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2018-12-03 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
33,358 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-11-29 |
4 |
AS |
$41.13 |
$163,232 |
I/I |
(3,900) |
27,478 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-11-28 |
4 |
AS |
$38.65 |
$151,803 |
I/I |
(3,900) |
31,378 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-11-15 |
4 |
AS |
$34.67 |
$137,509 |
I/I |
(3,900) |
35,278 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-11-14 |
4 |
AS |
$33.89 |
$132,543 |
I/I |
(3,900) |
39,178 |
|
- |
|
Marcus Joel S |
Director |
|
2018-11-07 |
4 |
S |
$36.35 |
$363,500 |
D/D |
(10,000) |
7,590 |
|
- |
|
Gallagher Carol Giltner |
Director |
|
2018-11-07 |
4 |
S |
$36.38 |
$777,586 |
D/D |
(21,374) |
88,818 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2018-11-01 |
4 |
AS |
$35.00 |
$52,500 |
D/D |
(1,500) |
31,858 |
|
- |
|
Newell Joe |
Chief Tech. Operations Officer |
|
2018-11-01 |
4 |
OE |
$20.40 |
$30,600 |
D/D |
1,500 |
33,358 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-10-23 |
4 |
AS |
$33.17 |
$133,045 |
I/I |
(3,900) |
43,078 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-10-22 |
4 |
AS |
$33.66 |
$131,751 |
I/I |
(3,900) |
46,978 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-10-05 |
4 |
AS |
$39.58 |
$155,777 |
I/I |
(3,900) |
50,878 |
|
- |
|
Ciechanover Isaac E. |
Chief Executive Officer |
|
2018-10-04 |
4 |
AS |
$40.09 |
$157,976 |
I/I |
(3,900) |
54,778 |
|
- |
|
736 Records found
|
|
Page 11 of 30 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|